Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 28 , ISSUE 10 ( October, 2024 ) > List of Articles

COMMENTARY

Inconsistencies in the Indian Guidelines for the Prescription of Antibiotics for Critically Ill Patients

Nikhil Raj, Soumya S Nath, Vikramjeet Singh, Jyotsna Agarwal

Keywords : Antibiotic guidelines, Critically ill patients, Diagnostic accuracy, Inhaled antibiotics, Respiratory infections

Citation Information : Raj N, Nath SS, Singh V, Agarwal J. Inconsistencies in the Indian Guidelines for the Prescription of Antibiotics for Critically Ill Patients. Indian J Crit Care Med 2024; 28 (10):908-911.

DOI: 10.5005/jp-journals-10071-24812

License: CC BY-NC 4.0

Published Online: 30-09-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

The recently formulated guidelines by Khilnani GC et al. for the prescription of antibiotics for critically ill patients present an extensive compilation of evidence and recommendations. Despite their comprehensive nature, several inconsistencies need addressing. In this commentary, we delve into some of these discrepancies in the order in which they appeared in the guidelines, starting with the misrepresentation of “nonbronchoscopic bronchoalveolar lavage (BAL)” and “mini BAL” as different techniques when they are, in fact, identical. Secondly, the Centers for Disease Control and Prevention (CDC) in the year 2013 replaced the older, unreliable ventilator-associated pneumonia (VAP) definition with ventilator-associated events (VAE). This new VAE definition eliminates subjectivity in pneumonia diagnosis by focusing on objective criteria for ventilator support changes, avoiding dependence on potentially inaccurate chest X-rays and inconsistent medical record keeping. Thus, using the term VAP in the Indian guidelines seems regressive. Furthermore, the recommendation for routine anaerobic coverage in aspiration pneumonia is outdated and unsupported by current evidence. Lastly, while endorsing multiplex polymerase chain reaction (PCR) for pathogen identification, the guidelines fail to adequately address its limitations and the risk of overdiagnosis.


PDF Share
  1. Khilnani GC, Zirpe K, Hadda V, Mehta Y, Madan K, Kulkarni A, et al. Guidelines for Antibiotic Prescription in Intensive Care Unit. Indian J Crit Care Med 2019;23(Suppl 1):S1–S63. DOI: 10.5005/jp-journals-10071-23101.
  2. Khilnani GC, Arafath TK, Hadda V, Kapil A, Sood S, Sharma SK. Comparison of bronchoscopic and non-bronchoscopic techniques for diagnosis of ventilator-associated pneumonia. Indian J Crit Care Med 2011;15(1):16–23. DOI: 10.4103/0972-5229.78218.
  3. Fernando SM, Tran A, Cheng W, Klompas M, Kyeremanteng K, Mehta S, et al. Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis. Intensive Care Med 2020;46(6):1170–1179. DOI: 10.1007/s00134-020-06036-z.
  4. Tang F, Zhu F, Wang Y, Xiankui Zha, Lyu L, Ma D. Role of bronchoscopy in the management of patients with suspected or suffering from ventilator-associated pneumonia: A meta-analysis. Heliyon 2024;10(12):e32751. DOI: 10.1016/j.heliyon.2024.e32751.
  5. Ventilator-associated events (VAE) published by the National Healthcare Safety Network of the Centre for Disease Control. Jan 2024. Available at https://www.cdc.gov/nhsn/pdfs/pscmanual/10-vae_final.pdf. (Last accessed on 27th June 2024).
  6. Sahana KS, Prabhu AS, Saldanha PR. Usage of cartridge based nucleic acid amplification test (CB-NAAT/GeneXpert) test as a diagnostic modality for pediatric tuberculosis; case series from Mangalore, South India. J Clin Tuberc Other Mycobact Dis 2017;11(1):7–9. DOI: 10.1016/j.jctube.2017.12.002.
  7. Tang R, Luo R, Wu B, Wang F, Song H, Chen X. Effectiveness and safety of adjunctive inhaled antibiotics for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials. J Crit Care 2021;65(1):133–139. DOI: 10.1016/j.jcrc.2021.06.004.
  8. Zhang X, Cui X, Jiang M, Huang S, Yang M. Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis. J Crit Care 2023;77(1):154315. DOI: 10.1016/j.jcrc.2023.154315.
  9. Rello J, Solé-Lleonart C, Rouby JJ, Chastre J, Blot S, Poulakou G, et al. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: A position paper from the European Society of Clinical Microbiology and Infectious diseases. Clin Microbiol Infect 2017;23(9):629–639. DOI: 10.1016/j.cmi.2017.04.011.
  10. Jung YJ, Kim EJ, Choi YH. Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia. Korean J Intern Med 2022;37(1):1–12. DOI: 10.3904/kjim.2021.277.
  11. Wang JL, Chen KY, Fang CT, Hsueh PR, Yang PC, Chang SC. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis 2005;40(7):915–922. DOI: 10.1086/428574.
  12. Yamasaki K, Kawanami T, Yatera K, Fukuda K, Noguchi S, Nagata S, et al. Significance of anaerobes and oral bacteria in community-acquired pneumonia. PLoS One 2013;8(5):e63103. DOI: 10.1371/journal.pone.0063103.
  13. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200(7):e45–e67. DOI: 10.1164/rccm.201908-1581ST.
  14. Chanderraj R, Baker JM, Kay SG, Brown CA, Hinkle KJ, Fergle DJ, et al. In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. Eur. Respir. J 2023;61(2):2200910. DOI: 10.1183/13993003.00910-2022.
  15. Kitsios GD, Nguyen VD, Sayed K, Al-Yousif N, Schaefer C, Shah FA, et al. The upper and lower respiratory tract microbiome in severe aspiration pneumonia. iScience 2023;26(6):106832. DOI: 10.1016/j.isci.2023.106832.
  16. Ramirez MM, Zarate MN, Rodriguez LA, Aquino VH. Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting. PLoS One 2023;18(10): e0292314. DOI: 10.1371/journal.pone.0292314.
  17. Cojuc-Konigsberg G, Moscona-Nissan A, Guijosa A, Mireles Dávalos CD, Martínez MEJ, Mújica Sánchez MA, et al. Diagnostic accuracy of the BioFire® FilmArray® pneumonia panel in COVID-19 patients with ventilator-associated pneumonia. BMC Infect Dis 2023;23(1):524. DOI: 10.1186/s12879-023-08486-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.